MONOCLONAL ANTIBODY FOR CANCER TREATMENT (Q3133637)

From EU Knowledge Graph
Revision as of 11:20, 23 March 2024 by DG Regio (talk | contribs) (‎Added qualifier: readability score (P590521): 0.0048376782437341)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Project Q3133637 in Spain
Language Label Description Also known as
English
MONOCLONAL ANTIBODY FOR CANCER TREATMENT
Project Q3133637 in Spain

    Statements

    country
    Spain
    0 references
    EU contribution
    28,123.695 Euro
    0 references
    budget
    56,247.39 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    16 February 2015
    0 references
    end time
    14 December 2015
    0 references
    beneficiary name (string)
    ALTHIA HEALTH S.L.
    0 references
    beneficiary
    Q3133636
    0 references
    programme
    Madrid - ERDF
    0 references
    coordinate location

    40°25'31.40"N, 3°40'57.14"W
    inferred from
    postal code
    0 references
    postal code
    28001
    0 references
    summary
    VALIDACIÓN DE UN ANTICUERPO MONOCLONAL PARA LA DETECCIÓN Y TRATAMIENTO DE CÉLULAS MADRE DEL CÁNCER EN TUMORES DE CEREBRO (Spanish)
    0 references
    VALIDATION OF A MONOCLONAL ANTIBODY FOR THE DETECTION AND TREATMENT OF CANCER MOTHER CELLS IN BRAIN TUMORS (English)
    readability score
    0.0048376782437341
    0 references
    VALIDATION D’UN ANTICORPS MONOCLONAL POUR LA DÉTECTION ET LE TRAITEMENT DES CELLULES SOUCHES CANCÉREUSES DANS LES TUMEURS CÉRÉBRALES (French)
    point in time
    2 December 2021
    0 references
    VALIDIERUNG EINES MONOKLONALEN ANTIKÖRPERS FÜR DEN NACHWEIS UND DIE BEHANDLUNG VON KREBSSTAMMZELLEN IN HIRNTUMOREN (German)
    point in time
    9 December 2021
    0 references
    VALIDATIE VAN EEN MONOKLONAAL ANTILICHAAM VOOR DETECTIE EN BEHANDELING VAN KANKERSTAMCELLEN IN HERSENTUMOREN (Dutch)
    point in time
    17 December 2021
    0 references
    CONVALIDA DI UN ANTICORPO MONOCLONALE PER L'INDIVIDUAZIONE E IL TRATTAMENTO DELLE CELLULE STAMINALI TUMORALI NEI TUMORI CEREBRALI (Italian)
    point in time
    16 January 2022
    0 references
    ΕΠΙΚΎΡΩΣΗ ΜΟΝΟΚΛΩΝΙΚΟΎ ΑΝΤΙΣΏΜΑΤΟΣ ΓΙΑ ΤΗΝ ΑΝΊΧΝΕΥΣΗ ΚΑΙ ΘΕΡΑΠΕΊΑ ΚΑΡΚΙΝΙΚΏΝ ΜΗΤΡΙΚΏΝ ΚΥΤΤΆΡΩΝ ΣΕ ΌΓΚΟΥΣ ΤΟΥ ΕΓΚΕΦΆΛΟΥ (Greek)
    point in time
    17 August 2022
    0 references
    VALIDERING AF ET MONOKLONALT ANTISTOF TIL PÅVISNING OG BEHANDLING AF KRÆFTMODERCELLER I HJERNETUMORER (Danish)
    point in time
    17 August 2022
    0 references
    MONOKLONAALISEN VASTA-AINEEN VALIDOINTI SYÖVÄN EMOSOLUJEN HAVAITSEMISEKSI JA HOITAMISEKSI AIVOKASVAIMISSA (Finnish)
    point in time
    17 August 2022
    0 references
    VALIDAZZJONI TA’ ANTIKORP MONOKLONALI GĦAS-SEJBIEN U T-TRATTAMENT TA’ ĊELLOLI OMM TAL-KANĊER F’TUMURI TAL-MOĦĦ (Maltese)
    point in time
    17 August 2022
    0 references
    MONOKLONĀLĀS ANTIVIELAS APSTIPRINĀŠANA VĒŽA MĀTES ŠŪNU NOTEIKŠANAI UN ĀRSTĒŠANAI SMADZEŅU AUDZĒJOS (Latvian)
    point in time
    17 August 2022
    0 references
    VALIDÁCIA MONOKLONÁLNEJ PROTILÁTKY NA DETEKCIU A LIEČBU RAKOVINOVÝCH MATERSKÝCH BUNIEK V MOZGOVÝCH NÁDOROCH (Slovak)
    point in time
    17 August 2022
    0 references
    ANTASUBSTAINT MHONACLÓNACH A BHAILÍOCHTÚ CHUN MÁTHAIRCHEALLA AILSE A BHRATH AGUS A CHÓIREÁIL I SIADAÍ INCHINNE (Irish)
    point in time
    17 August 2022
    0 references
    VALIDACE MONOKLONÁLNÍ PROTILÁTKY PRO DETEKCI A LÉČBU NÁDOROVÝCH MATEŘSKÝCH BUNĚK V MOZKOVÝCH NÁDORECH (Czech)
    point in time
    17 August 2022
    0 references
    VALIDAÇÃO DE UM ANTICORPO MONOCLONAL PARA A DETEÇÃO E TRATAMENTO DE CÉLULAS-MÃE CANCERÍGENAS EM TUMORES CEREBRAIS (Portuguese)
    point in time
    17 August 2022
    0 references
    MONOKLONAALSE ANTIKEHA VALIDEERIMINE VÄHIEMARAKKUDE AVASTAMISEKS JA RAVIKS AJUKASVAJATES (Estonian)
    point in time
    17 August 2022
    0 references
    MONOKLONÁLIS ANTITEST VALIDÁLÁSA AZ AGYDAGANATOK RÁKOS ANYASEJTJEINEK KIMUTATÁSÁRA ÉS KEZELÉSÉRE (Hungarian)
    point in time
    17 August 2022
    0 references
    ВАЛИДИРАНЕ НА МОНОКЛОНАЛНО АНТИТЯЛО ЗА ОТКРИВАНЕ И ЛЕЧЕНИЕ НА РАКОВИ МАЙЧИНИ КЛЕТКИ ПРИ МОЗЪЧНИ ТУМОРИ (Bulgarian)
    point in time
    17 August 2022
    0 references
    MONOKLONINIO ANTIKŪNO PATVIRTINIMAS SMEGENŲ NAVIKŲ VĖŽIO MOTININĖMS LĄSTELĖMS NUSTATYTI IR GYDYTI (Lithuanian)
    point in time
    17 August 2022
    0 references
    VALIDACIJA MONOKLONSKOG PROTUTIJELA ZA OTKRIVANJE I LIJEČENJE MATIČNIH STANICA RAKA U TUMORIMA MOZGA (Croatian)
    point in time
    17 August 2022
    0 references
    VALIDERING AV EN MONOKLONAL ANTIKROPP FÖR UPPTÄCKT OCH BEHANDLING AV CANCERMODERCELLER I HJÄRNTUMÖRER (Swedish)
    point in time
    17 August 2022
    0 references
    VALIDAREA UNUI ANTICORP MONOCLONAL PENTRU DETECTAREA ȘI TRATAMENTUL CELULELOR MAMARE CANCEROASE ÎN TUMORILE CEREBRALE (Romanian)
    point in time
    17 August 2022
    0 references
    POTRDITEV MONOKLONSKEGA PROTITELESA ZA ODKRIVANJE IN ZDRAVLJENJE RAKAVIH MATIČNIH CELIC PRI MOŽGANSKIH TUMORJIH (Slovenian)
    point in time
    17 August 2022
    0 references
    WALIDACJA PRZECIWCIAŁ MONOKLONALNYCH DO WYKRYWANIA I LECZENIA KOMÓREK MACIERZYSTYCH NOWOTWORÓW W GUZACH MÓZGU (Polish)
    point in time
    17 August 2022
    0 references
    location (string)
    Madrid
    0 references
    date of last update
    21 December 2023
    0 references

    Identifiers

    Spanish Kohesio ID
    DGEPF/01/21/002-17/18
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3133637&oldid=41807197"